From 1 October, a large number of drugs could not be reimbursed

Not long ago, the Beijing Municipal Medical Security Bureau and the Municipal Bureau of Human Resources and Social Security jointly issued the "Notice on the publication of the first batch of non-national medical insurance drug catalog drug varieties in Beijing", which clearly: from October 1 this year, benzodialyc, ibuprofen and other 224 kinds of non-national medical insurance drug catalog varieties from the city's medical insurance drug catalog.
October 1st, a large number of drugs could not be reimbursed (Photo: Pharmaceutical Network) Specifically, a total of 136 Western medicines and 88 Chinese medicines were transferred out.
Among them, there are some common drugs, such as phenylethylphenidate for the treatment of diabetes, halomisone for the treatment of skin diseases, antibiotic-type drugs Klinmycin, anti-heat analgesic drug ibuprofen and anti-snake serum injection preparations, children's cold heat tablets, cold heat-relieving particles, compound dansin injections, ten drops of water capsules, leprosy capsules, etc.
It is learned that the main reason why Beijing transferred a large number of drugs this time, in order to implement the "three years to gradually digest the local medical insurance catalog of non-national medical insurance drug varieties" this unified national requirements, and the follow-up medical insurance drug catalog may be adjusted accordingly.
fact, many health insurance bureaus have been sending out intensive messages this year, specifying that large quantities of drugs will no longer be reimbursed.
According to incomplete statistics, as of July, Yunnan, Hunan, Jilin, Tianjin, Hebei, Anhui, Tibet and other places have clearly the first batch of additional varieties of local health insurance, and a large number of varieties have been transferred out of the local health insurance directory.
e.g. on June 29, Hebei Provincial Health Insurance Bureau issued the "on the 2020 digestion out of Hebei Province's medical insurance drug catalog temporarily retained additional drugs" said, in order to implement the State Health Insurance Administration on "by the end of June this year to remove the national key monitoring varieties out of the catalog and complete 40% of the province's additional varieties of digestion" deployment requirements, Hebei Province will be proposed to transfer the list of additional drugs.
, a total of 171 varieties have been published in Hebei Province, which have been transferred out of The Health Insurance Directory in Hebei Province since July 1.
On July 1, Yunnan Medical Insurance Bureau issued a notice of the Drug Digestion and Adjustment Program for the Scope of yunnan Province's Super-National Medical Insurance Drug Catalog, speaking that, in order to strictly implement the 2019 Edition of the National Drug Catalog, from June 30, 2020 at 24:00, the 2019 edition of the National Drug Catalog will be synchronized with the transfer of drugs, drugs that exceed the state medical insurance payment dosage forms, compound drugs, and Chinese medicine tablets that the state has expressly not paid for.
, Yunnan Province, the scope of the super-national medical insurance catalogue of 837 drugs, of which 416 Western medicine, 421 Chinese medicine.
In general, as the clean-up of non-state health insurance drug varieties accelerates, more and more drugs with high prices, insociable clinical efficacy and obvious therapeutic advantages will be accelerated out of health insurance, which will be a huge challenge for some enterprises and pharmacies.
for pharmaceutical companies, in the context of the overall more dynamic adjustment of health care, it is necessary to accelerate the approach to the value of health insurance, pay attention to the clinical safety and effectiveness of drug use, and further improve the cost-effective products.
for pharmacies, it is necessary to combine the actual situation of local hospital sales to carry out differentiated "play" to maintain market share.
addition, to maintain a good pharmacy has always been all the "convenience" advantages, to provide can help the actual drug guidance, may be the key to the sustainable development of pharmacies in the future.